The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors
Συγγραφείς: Christine R. Cuthbertson, Hui Guo, Armita Kyani, Joseph T. Madak, Zahra Arabzada, Nouri Neamati
Πηγή: ACS Pharmacology & Translational Science. 3:1242-1252
Στοιχεία εκδότη: American Chemical Society (ACS), 2020.
Έτος έκδοσης: 2020
Θεματικοί όροι: 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, 3. Good health
Περιγραφή: The dihydroorotate dehydrogenase (DHODH) inhibitor brequinar failed all clinical trials for solid tumors. To investigate mechanisms to increase brequinar's efficacy, we employed a combination strategy to simultaneously inhibit the nucleotide salvage pathways. Brequinar is synergistic with the equilibrative nucleoside transporter (ENT) inhibitor dipyridamole, but not the concentrative nucleoside transporter inhibitor phlorizin. This synergy carries over to ENT1/2 inhibition, but not ENT4. Our previously described brequinar analogue 41 was also synergistic with dipyridamole as were the FDA-approved DHODH inhibitors leflunomide and teriflunomide but the latter required much higher concentrations than brequinar. Therefore, a combination of brequinar and ENT inhibitors presents a potential anti-cancer strategy in select tumors.
Τύπος εγγράφου: Article
Other literature type
Γλώσσα: English
ISSN: 2575-9108
DOI: 10.1021/acsptsci.0c00124
Σύνδεσμος πρόσβασης: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737209
https://pubmed.ncbi.nlm.nih.gov/33344900
https://pubmed.ncbi.nlm.nih.gov/33344900/
https://pubs.acs.org/doi/10.1021/acsptsci.0c00124
https://pubs.acs.org/doi/full/10.1021/acsptsci.0c00124
https://www.ncbi.nlm.nih.gov/pubmed/33344900
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737209
Rights: STM Policy #29
Αριθμός Καταχώρησης: edsair.doi.dedup.....ee19d810692bf2992bfaed9304b0e420
Βάση Δεδομένων: OpenAIRE
Περιγραφή
ISSN:25759108
DOI:10.1021/acsptsci.0c00124